These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
578 related articles for article (PubMed ID: 9375865)
1. IgG subclasses of antibodies to type II collagen in rheumatoid arthritis differ from those in systemic lupus erythematosus and other connective tissue diseases. Cook AD; Mackay IR; Cicuttini FM; Rowley MJ J Rheumatol; 1997 Nov; 24(11):2090-6. PubMed ID: 9375865 [TBL] [Abstract][Full Text] [Related]
2. IgG subclass distribution of antinative type II collagen and antidenatured type II collagen antibodies in patients with rheumatoid arthritis. Collins I; Morgan K; Clague RB; Brenchley PE; Holt PJ J Rheumatol; 1988; 15(5):770-4. PubMed ID: 3050082 [TBL] [Abstract][Full Text] [Related]
3. Epitope-specific recognition of type II collagen by rheumatoid arthritis antibodies is shared with recognition by antibodies that are arthritogenic in collagen-induced arthritis in the mouse. Burkhardt H; Koller T; Engström A; Nandakumar KS; Turnay J; Kraetsch HG; Kalden JR; Holmdahl R Arthritis Rheum; 2002 Sep; 46(9):2339-48. PubMed ID: 12355481 [TBL] [Abstract][Full Text] [Related]
4. Antibodies to the collagen-like region of C1q and type II collagen are independent non-cross-reactive populations in systemic lupus erythematosus and rheumatoid arthritis. Cook AD; Rowley MJ; Wines BD; Mackay IR J Autoimmun; 1994 Jun; 7(3):369-78. PubMed ID: 7522456 [TBL] [Abstract][Full Text] [Related]
5. Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases: antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus. Amoura Z; Koutouzov S; Chabre H; Cacoub P; Amoura I; Musset L; Bach JF; Piette JC Arthritis Rheum; 2000 Jan; 43(1):76-84. PubMed ID: 10643702 [TBL] [Abstract][Full Text] [Related]
6. Prevalence of anti-3-nitrotyrosine antibodies in the joint synovial fluid of patients with rheumatoid arthritis, osteoarthritis and systemic lupus erythematosus. Khan F; Siddiqui AA Clin Chim Acta; 2006 Aug; 370(1-2):100-7. PubMed ID: 16513103 [TBL] [Abstract][Full Text] [Related]
7. IgG subclass distribution of anticardiolipin antibody in patients with systemic lupus erythematosus. Tsutsumi A; Koike T; Ichikawa K; Shimada K; Takabayashi K; Tomioka H; Yoshida S J Rheumatol; 1988 Dec; 15(12):1764-7. PubMed ID: 3265958 [TBL] [Abstract][Full Text] [Related]
8. IgG antibodies to type II collagen reflect inflammatory activity in patients with rheumatoid arthritis. Kim WU; Yoo WH; Park W; Kang YM; Kim SI; Park JH; Lee SS; Joo YS; Min JK; Hong YS; Lee SH; Park SH; Cho CS; Kim HY J Rheumatol; 2000 Mar; 27(3):575-81. PubMed ID: 10743792 [TBL] [Abstract][Full Text] [Related]
9. Distribution of IgG subclasses among human autoantibodies to Sm, RNP, dsDNA, SS-B and IgG rheumatoid factor. Yount WJ; Cohen P; Eisenberg RA Monogr Allergy; 1988; 23():41-56. PubMed ID: 2968502 [TBL] [Abstract][Full Text] [Related]
10. IgG subclasses of autoantibodies in systemic lupus erythematosus, Sjogren's syndrome, and drug-induced autoimmunity. Rubin RL; Tang FL; Chan EK; Pollard KM; Tsay G; Tan EM J Immunol; 1986 Oct; 137(8):2528-34. PubMed ID: 3760566 [TBL] [Abstract][Full Text] [Related]
11. IgG, IgA, IgM antibodies to a viral citrullinated peptide in patients affected by rheumatoid arthritis, chronic arthritides and connective tissue disorders. Anzilotti C; Riente L; Pratesi F; Chimenti D; Delle Sedie A; Bombardieri S; Migliorini P Rheumatology (Oxford); 2007 Oct; 46(10):1579-82. PubMed ID: 17717033 [TBL] [Abstract][Full Text] [Related]
12. IgG1 and IgG4 are the predominant subclasses among auto-antibodies against two citrullinated antigens in RA. Engelmann R; Brandt J; Eggert M; Karberg K; Krause A; Neeck G; Mueller-Hilke B Rheumatology (Oxford); 2008 Oct; 47(10):1489-92. PubMed ID: 18703528 [TBL] [Abstract][Full Text] [Related]
13. IgG subclass distribution of the rheumatoid arthritis-specific autoantibodies to citrullinated fibrin. Chapuy-Regaud S; Nogueira L; Clavel C; Sebbag M; Vincent C; Serre G Clin Exp Immunol; 2005 Mar; 139(3):542-50. PubMed ID: 15730401 [TBL] [Abstract][Full Text] [Related]
14. Serial analysis of autoantibody responses to the collagen-like region of Clq, collagen type II, and double stranded DNA in patients with systemic lupus erythematosus. Sjoholm AG; Martensson U; Sturfelt G J Rheumatol; 1997 May; 24(5):871-8. PubMed ID: 9150075 [TBL] [Abstract][Full Text] [Related]
15. [Humoral and cellular anticollagen autoimmunity in rheumatic pathology]. Gioud M; Monier JC; Bonvoisin B; Meghlaoui A; Venet C; Lejeune E; Bouvier M Rev Rhum Mal Osteoartic; 1983; 50(8-9):579-83. PubMed ID: 6356308 [TBL] [Abstract][Full Text] [Related]
16. Measurement and characterisation of circulating anti-endothelial cell IgG in connective tissue diseases. Rosenbaum J; Pottinger BE; Woo P; Black CM; Loizou S; Byron MA; Pearson JD Clin Exp Immunol; 1988 Jun; 72(3):450-6. PubMed ID: 3168322 [TBL] [Abstract][Full Text] [Related]
17. Correlation between anti-C1q and immune conglutinin levels, but not between levels of antibodies to the structurally related autoantigens C1q and type II collagen in SLE or RA. Rönnelid J; Gunnarsson I; Nilsson-Ekdahl K; Nilsson B J Autoimmun; 1997 Aug; 10(4):415-23. PubMed ID: 9237806 [TBL] [Abstract][Full Text] [Related]
18. Complement fixing activity and immunoglobulin classes of antinuclear antibodies occurring in systemic lupus erythematosus and rheumatoid arthritis. Massonnet-Castel S; Cassuto JP; Rioche M; Mucchielli A; Masseyeff R Biomedicine; 1981 Feb; 34(1):40-6. PubMed ID: 6971657 [TBL] [Abstract][Full Text] [Related]
19. [Anti-type II collagen antibodies in collagen disease]. Fukasawa Y; Kano S Rinsho Byori; 1993 Aug; 41(8):876-81. PubMed ID: 8371503 [TBL] [Abstract][Full Text] [Related]
20. Increased levels of autoantibodies against catalase and superoxide dismutase associated with oxidative stress in patients with rheumatoid arthritis and systemic lupus erythematosus. Mansour RB; Lassoued S; Gargouri B; El Gaïd A; Attia H; Fakhfakh F Scand J Rheumatol; 2008; 37(2):103-8. PubMed ID: 18415766 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]